X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (766) 766
continuous subcutaneous insulin infusion (640) 640
index medicus (540) 540
female (495) 495
male (462) 462
endocrinology & metabolism (459) 459
type 1 diabetes (411) 411
continuous glucose monitoring (395) 395
insulin - administration & dosage (370) 370
diabetes mellitus, type 1 - drug therapy (362) 362
diabetes (356) 356
adult (347) 347
insulin (347) 347
insulin infusion systems (314) 314
hypoglycemia (278) 278
diabetes mellitus, type 1 - blood (267) 267
hypoglycemic agents - administration & dosage (265) 265
middle aged (258) 258
glucose (256) 256
blood glucose - analysis (229) 229
glycemic control (224) 224
insulin - therapeutic use (181) 181
blood glucose - metabolism (179) 179
diabetes mellitus (175) 175
insulin pump (172) 172
children (165) 165
adolescent (144) 144
hypoglycemic agents - therapeutic use (140) 140
child (138) 138
medicine & public health (133) 133
therapy (130) 130
blood sugar monitoring (127) 127
aged (124) 124
treatment outcome (124) 124
type 1 diabetes mellitus (124) 124
adolescents (123) 123
multiple daily injections (118) 118
pediatrics (118) 118
infusion (116) 116
internal medicine (115) 115
pump therapy (105) 105
mellitus (102) 102
hyperglycemia (100) 100
diabetes therapy (98) 98
care and treatment (97) 97
glycated hemoglobin a - analysis (96) 96
type 2 diabetes (92) 92
injections, subcutaneous (91) 91
original (90) 90
quality of life (88) 88
artificial pancreas (87) 87
original articles (85) 85
glycated hemoglobin a - metabolism (83) 83
time factors (83) 83
blood sugar (80) 80
dextrose (79) 79
young adult (79) 79
analysis (78) 78
blood-glucose (78) 78
insulin pumps (73) 73
blood glucose self-monitoring (72) 72
blood glucose self-monitoring - instrumentation (72) 72
severe hypoglycemia (72) 72
pregnancy (71) 71
blood glucose - drug effects (70) 70
infusions, subcutaneous (70) 70
insulin - adverse effects (70) 70
insulin pump therapy (70) 70
retrospective studies (69) 69
blood glucose self-monitoring - methods (68) 68
hypoglycemic agents - adverse effects (68) 68
metabolic diseases (68) 68
adults (67) 67
diabetes mellitus, type 2 - drug therapy (67) 67
hypoglycaemia (66) 66
algorithms (64) 64
usage (64) 64
complications (62) 62
health aspects (62) 62
management (62) 62
hypoglycemia - prevention & control (60) 60
quality-of-life (60) 60
drug administration schedule (59) 59
blood glucose (58) 58
child, preschool (57) 57
animals (55) 55
pharmacology & pharmacy (55) 55
review (55) 55
sensors (55) 55
diabetes mellitus - drug therapy (54) 54
glycosylated hemoglobin (54) 54
insulin infusion systems - adverse effects (54) 54
csii (53) 53
accuracy (52) 52
patient monitoring equipment (51) 51
type-1 (51) 51
injections (50) 50
research (50) 50
diabetes mellitus, type 2 - blood (49) 49
prospective studies (49) 49
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1252) 1252
German (37) 37
Spanish (27) 27
Japanese (13) 13
French (11) 11
Polish (7) 7
Czech (6) 6
Korean (6) 6
Italian (5) 5
Hungarian (2) 2
Icelandic (2) 2
Chinese (1) 1
Estonian (1) 1
Finnish (1) 1
Portuguese (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes/Metabolism Research and Reviews, ISSN 1520-7552, 01/2016, Volume 32, Issue 1, pp. 21 - 39
... (T1DM) typically requires intensified insulin therapy using multiple daily injections or continuous subcutaneous insulin infusion... 
continuous subcutaneous insulin infusion | diabetes mellitus | rapid‐acting insulin analogue | pharmacoeconomics | pregnancy | paediatric | Pregnancy | Rapid-acting insulin analogue | Pharmacoeconomics | Paediatric | Diabetes mellitus | Continuous subcutaneous insulin infusion | MULTIPLE DAILY INJECTIONS | GLYCEMIC CONTROL | ARTIFICIAL PANCREAS | SEVERE HYPOGLYCEMIA | AUGMENTED PUMP THERAPY | RANDOMIZED CONTROLLED-TRIAL | METABOLIC-CONTROL | CLOSED-LOOP CONTROL | rapid-acting insulin analogue | ENDOCRINOLOGY & METABOLISM | QUALITY-OF-LIFE | BLOOD-GLUCOSE CONTROL | Insulin, Short-Acting - adverse effects | Insulin, Short-Acting - economics | Hypoglycemic Agents - economics | Insulin, Short-Acting - administration & dosage | Humans | Insulins - economics | Hypoglycemia - prevention & control | Hypoglycemic Agents - administration & dosage | Computer Security | Insulin Infusion Systems - economics | Hypoglycemia - chemically induced | Precision Medicine | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Blood Glucose - analysis | Insulins - administration & dosage | Europe | Insulin Infusion Systems - adverse effects | Evidence-Based Medicine | Insulin Infusion Systems - trends | Diabetes Mellitus, Type 1 - drug therapy | Infusions, Subcutaneous | Monitoring, Ambulatory | Health Care Costs | Diabetes Mellitus, Type 1 - economics | Diabetes Mellitus, Type 1 - blood | Quality of Life | Insulins - therapeutic use | Hypoglycemic Agents - adverse effects | Insulins - adverse effects | Insulin, Short-Acting - therapeutic use | Insulin | Diabetes | Hyperglycemia | Patient satisfaction | Quality of life | Life Sciences | Human health and pathology | Endocrinology and metabolism | Review
Journal Article
Journal Article
Diabetes & Metabolism, ISSN 1262-3636, 2011, Volume 37, Issue 5, pp. 426 - 431
Journal Article
Endocrine, ISSN 1355-008X, 1/2017, Volume 55, Issue 1, pp. 77 - 84
Journal Article
Journal Article